Afirma Assay by Veracyte
January 16, 2012Palmetto GBA has completed the Afirma assessment and determined that the test meets criteria for analytical and clinical validity, and clinical utility as a reasonable and necessary Medicare benefit. Effective January 1, 2012, Palmetto GBA will reimburse Afirma services. Palmetto GBA expects this test will be performed once in a patient’s lifetime. Medicare Part A and Part B MAC for Jurisdiction 1